Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Parkinson’s Disease Dementia

bmi2 - kraepelin3 - pseudodementia2 - napa1 - cognitive deterioration2 - a-beta protein1 - transient ischemic attack1 - entorhinal cortex1 - university of california2 - slowness of movement1 - tasigna1 - dementia with lewy bodies3 - reducing anxiety1 - chronic sleep deprivation1 - memory capacity1 - parkinson disease3 - meryl streep1 - chuanhai cao1 - electroencephalogram1 - adam101 - leg tremors1 - protein tau2 - alzheimer sufferer1 - blood vessels1 - igfbp-31 - hypertensive1 - diabetes mellitus1 - social support1 - sahlgrenska academy1 - myxoedema1 -